View:
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 15 )* --------- Abbott Laboratories - ----------------------------------------------------------------------------- (Name of Issuer) Common shares without par value - ----------------------------------------------------------------------------- (Title of Class of Securities) 002824-10-0 ------------------------------ (CUSIP Number) Check the following box if a fee is being paid with this statement / /. (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7). *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (Continued on following page (s)) Page 1 of 7 pages CUSIP No. 002824-10-0 13G Page 2 of 7 pages - ----------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Abbott Laboratories Stock Retirement Trust I.R.S. Identification No. 36-6047554 - ----------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / / (b) /x/ - ----------------------------------------------------------------------------- 3 SEC USE ONLY - ----------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Illinois - ----------------------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES 0 BENEFICIALLY -------------------------------------------------------- OWNED BY 6 SHARED VOTING POWER EACH 64,148,697 REPORTING -------------------------------------------------------- PERSON 7 SOLE DISPOSITIVE POWER WITH 0 -------------------------------------------------------- 8 SHARED DISPOSITIVE POWER 64,148,697 - ----------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 64,148,697 - ----------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* /x/ - ----------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.8% - ----------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* EP - ----------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! CUSIP No. 002824-10-0 13G Page 3 of 7 pages - ----------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Gary P. Coughlan ###-##-#### - ----------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / / (b) /x/ - ----------------------------------------------------------------------------- 3 SEC USE ONLY - ----------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States - ----------------------------------------------------------------------------- 5 SOLE VOTING POWER (Does not include shares held in Abbott 74,916 shares - Laboratories Stock Retirement Trust for the direct benefit of the reporting person.) -------------------------------------------------------------- NUMBER OF 6 SHARED VOTING POWER SHARES 64,148,697 - as Trustee, Abbott Laboratories Stock BENEFICIALLY shares Retirement Trust OWNED BY 1,085,640 - as Director, Abbott Laboratories Fund. EACH -------------------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON WITH 74,916 shares (See note in 5 above) -------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER 64,148,697 as Trustee, Abbott Laboratories Stock shares Retirement Trust. 1,085,640 as Director, Abbott Laboratories Fund. - ----------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 65,392,809 (Total of 5 + 6 + 83,556 shares - right to acquire by exercise of stock options) - ----------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - ----------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 8.0% - ----------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IN - ----------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! CUSIP No. 002824-10-0 13G Page 4 of 7 pages - ----------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Thomas C. Freyman ###-##-#### - ----------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / / (b) /x/ - ----------------------------------------------------------------------------- 3 SEC USE ONLY - ----------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States - ----------------------------------------------------------------------------- 5 SOLE VOTING POWER (Does not include shares held in Abbott 20,805 shares - Laboratories Stock Retirement Trust for the direct benefit of the reporting person.) -------------------------------------------------------------- NUMBER OF 6 SHARED VOTING POWER SHARES as Trustee, Abbott Laboratories Stock BENEFICIALLY 64,148,697 - Retirement Trust OWNED BY EACH -------------------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON WITH 20,805 shares (See note in 5 above) -------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER 64,148,697 as Trustee, Abbott Laboratories Stock shares Retirement Trust. - ----------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 64,185,368 (Total of 5 + 6 + 15,866 shares - right to acquire by exercise of stock options) - ----------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - ----------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.8% - ----------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IN - ----------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! CUSIP No. 002824-10-0 13G Page 5 of 7 pages - ----------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Ellen M. Walvoord ###-##-#### - ----------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / / (b) /x/ - ----------------------------------------------------------------------------- 3 SEC USE ONLY - ----------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States - ----------------------------------------------------------------------------- 5 SOLE VOTING POWER (Does not include shares held in Abbott 19,000 shares - Laboratories Stock Retirement Trust for the direct benefit of the reporting person.) -------------------------------------------------------------- NUMBER OF 6 SHARED VOTING POWER SHARES 64,148,697 - as Trustee, Abbott Laboratories Stock BENEFICIALLY shares Retirement Trust OWNED BY -------------------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON 19,000 shares (See note in 5 above) WITH REPORTING -------------------------------------------------------------- PERSON 8 SHARED DISPOSITIVE POWER WITH 64,148,697 - as Trustee, Abbott Laboratories Stock shares Retirement Trust. - ----------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 64,192,033 (Total of 5 + 6 + 24,336 shares - right to acquire by exercise of stock options) - ----------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - ----------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.8% - ----------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IN - ----------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! Item 1(a) Name of Issuer: Abbott Laboratories Item 1(b) Address of Issuers's Principal Executive Offices: One Abbott Park Road Abbott Park, Illinois 60064-3500 Item 2(a) Name of Persons Filing: Abbott Laboratories Stock Retirement Trust Gary P. Coughlan Thomas C. Freyman Ellen M. Walvoord Item 2(b) Address of Principal Business Office: One Abbott Park Road Abbott Park, Illinois 60064-3500 Item 2(c) Citizenship: Abbott Laboratories Stock Retirement Trust - Illinois. Gary P. Coughlan, Thomas C. Freyman, and Ellen M. Walvoord - United States Item 2(d) Title of Class of Securities: Common shares without par value Item 2(e) CUSIP Number: 002824 10 0 Item 3. If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b), check whether the person filing is an: [X] Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974. Item 4. Ownership (a) (See cover pages 2, 3, (b) 4 and 5, Items 5 through (c) 9 and 11.) Item 5. Ownership of Five Percent or Less of a Class Not applicable. Page 6 of 7 pages Item 6. Ownership of More than Five Percent on Behalf of Another Person. The shares owned by the Abbott Laboratories Stock Retirement Trust and the dividends thereon are held for the benefit of participants of the Abbott Laboratories Stock Retirement Plan pursuant to terms of that Plan and the Trust. The Abbott Laboratories Stock Retirement Plan is a qualified profit sharing plan. As of December 31, 1993, there were 35,148 participants with share balances in the Plan. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certification. Not applicable. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. This statement is filed on behalf of each individual listed below pursuant to their agreement. February 11, 1994 ------------------------------ Date /s/ Gary P. Coughlan - ------------------------------ ABBOTT LABORATORIES STOCK Gary P. Coughlan RETIREMENT TRUST /s/ Thomas C. Freyman - ------------------------------ Thomas C. Freyman /s/ Ellen M. Walvoord /s/ Thomas C. Freyman - ------------------------------ ------------------------------ Ellen M. Walvoord Thomas C. Freyman, Chairman of Trustees, Abbott Laboratories Stock Retirement Trust Page 7 of 7 pages DISCLAIMER OF BENEFICIAL OWNERSHIP UNDER RULE 13d-4 The filing of Schedule 13G Amendment 15 on behalf of the Abbott Laboratories Stock Retirement Trust does not constitute an admission that the undersigned is, for purposes of Section 13(d) of the Securities and Exchange Act of 1934, the beneficial owner of any securities covered by the Schedule. Pursuant to Rule 13d-4 of the Act, the undersigned disclaims such ownership with respect to any shares listed therein of which he would not otherwise be deemed to be beneficial owner. /s/ Gary P. Coughlan ------------------------------ Gary P. Coughlan February 11, 1994 ------------------------------ Date DISCLAIMER OF BENEFICIAL OWNERSHIP UNDER RULE 13d-4 The filing of Schedule 13G Amendment 15 on behalf of the Abbott Laboratories Stock Retirement Trust does not constitute an admission that the undersigned is, for purposes of Section 13(d) of the Securities and Exchange Act of 1934, the beneficial owner of any securities covered by the Schedule. Pursuant to Rule 13d-4 of the Act, the undersigned disclaims such ownership with respect to any shares listed therein of which he would not otherwise be deemed to be beneficial owner. /s/ Thomas C. Freyman ------------------------------ Thomas C. Freyman February 11, 1994 ------------------------------ Date DISCLAIMER OF BENEFICIAL OWNERSHIP UNDER RULE 13d-4 The filing of Schedule 13G Amendment 15 on behalf of the Abbott Laboratories Stock Retirement Trust does not constitute an admission that the undersigned is, for purposes of Section 13(d) of the Securities and Exchange Act of 1934, the beneficial owner of any securities covered by the Schedule. Pursuant to Rule 13d-4 of the Act, the undersigned disclaims such ownership with respect to any shares listed therein of which she would not otherwise be deemed to be beneficial owner. /s/ Ellen M. Walvoord ------------------------------ Ellen M. Walvoord February 11, 1994 ------------------------------ Date SEC/13G Form